‌

US Patent 11123399 Modulators of complement activity

Patent 11123399 was granted and assigned to Ra Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Ra Pharmaceuticals

Current Assignee

Ra Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Vaishnavi Rajagopal0

Alonso Ricardo0

Douangsone D. Vadysirisack0

Douglas A. Treco0

Guo-Qing Tang0

Kathleen Seyb0

Michelle Denise Hoarty0

Ramin Farzaneh-Far0

...

Date of Patent

September 21, 2021

Patent Application Number

20171207

Date Filed

December 7, 2017

Patent Citations Received

US Patent 11965040 Modulation of complement activity

0

US Patent 11752190 Modulators of complement activity

Patent abstract

The present disclosure relates to polypeptide modulators of complement activity, including cyclic polypeptide modulators. Included are methods of utilizing such modulators as therapeutics. Also provided are methods of measuring C5 and related complexes using C5 binding agents.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11123399 Modulators of complement activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.